What is the company history, ownership, and supply chain for Rosabella Moringa’s moringa sourcing?
Executive summary
Rosabella Moringa is sold through a family of branded sites that present the product as a U.S.-market supplement with a 90‑day satisfaction guarantee and customer-facing operations tied to Ambrosia Brands LLC in Cheyenne, Wyoming [1] [2]. Public materials claim ethical sourcing and U.S. manufacturing in a cGMP facility but also point to a Chinese contract manufacturer listing for Xi’an Ebos Biotech—revealing contradictory supply‑chain signals that cannot be fully reconciled from available sources [3] [4] [5].
1. Company identity and public storefronts
The Rosabella brand operates multiple direct‑to‑consumer sites (tryrosabella.com, getrosabella.com, itsrosabella.com) that pitch a proprietary moringa formulation, promote a 90‑day refund policy, and emphasize high‑volume retail positioning including wholesale partnerships [6] [1] [7] [8]. Customer reviews on platforms like Trustpilot reinforce active consumer channels and repeat sales narratives, which align with a consumer‑direct marketing strategy rather than traditional retail branding [9].
2. Ownership and corporate contact information
The company lists Ambrosia Brands LLC with a Cheyenne, Wyoming address and a customer service contact on its contact page, identifying a U.S. corporate presence responsible for sales and consumer support [2]. Public marketing and storefront content consistently present Rosabella as a U.S. seller, but none of the provided sources supply corporate filings, executive names, or detailed ownership structure beyond that Ambrosia Brands LLC listing [2]. That absence limits confirmation of ultimate owners or parent companies from these materials alone.
3. Manufacturing claims: USA cGMP versus overseas OEM
Retail product pages assert manufacturing in a New Jersey cGMP (current Good Manufacturing Practice) certified facility and state “made in the USA” for mushrooms and supplements, language intended to assure quality control [4]. By contrast, a third‑party supplier/manufacturer page explicitly marketing “Rosabella Moringa Capsule” lists Xi’an Ebos Biotech Co., Ltd., a China‑based contract manufacturer, as the factory producing Rosabella Moringa capsules—an explicit conflict with the US manufacturing claim in other materials [5]. Both claims appear in public sources; the documents do not provide batch certificates, third‑party lab reports, or contractual evidence to reconcile them.
4. Sourcing narrative for moringa leaf material
Product copy repeatedly states the moringa is “passionately grown” and “ethically sourced” and emphasizes potency per serving (800 mg per two capsules), but it does not specify country of origin for the moringa leaf powder on those product pages [3]. Wider market context shows major moringa ingredient suppliers source from India, Africa, and Ghana specifically, and industry lists point to suppliers practicing farmer engagement and sustainable procurement—yet none of those broader supplier profiles are tied directly to Rosabella in the available material [10] [11]. Therefore, Rosabella’s public claims on ethics and sourcing are marketing statements not substantiated by traceable origin documentation in the sources provided.
5. Commercial footprint and market signals
Third‑party retail intelligence and B2B summaries indicate Rosabella Moringa enjoys high sales volumes among moringa capsules and is offered wholesale, suggesting strong market demand and distribution via both direct and reseller channels [11] [8]. Trustpilot reviews and promotional bundle pricing also reflect aggressive direct‑response marketing tactics—discounted bundles and testimonials—common to subscription and DTC supplement brands [9] [6].
6. Areas of uncertainty and why it matters
Key gaps remain: definitive proof of where the moringa leaf is grown and processed, the exact manufacturing site for each SKU, and corporate ownership beyond Ambrosia Brands LLC are not documented in the provided sources [2] [3] [5]. Those absent records limit verification of ethical sourcing claims and of whether the product is wholly U.S. manufactured or produced overseas under private‑label arrangements. Consumers and regulators typically rely on batch certificates, COAs, and supply contracts to resolve such questions—documents not present in the reporting assembled here.